indirectly dealing in Active Pharmaceutical Ingredient (API), pharmaceutical products, or formulations containing Vildagliptin alone or Vildagliptin in combination with any other compound ... manufacture and sale of infringing pharmaceutical products or formulation or combination containing Vildagliptin alone or Vildagliptin in combination in any form and a decree
prices of the oral diabetes drugs containing the
Active Pharmaceutical Ingredient (API) Vildagliptin. In addition to
LPA 658/2018 Page 2 of 12
the pricing
prices of the oral diabetes drugs containing the Active Pharmaceutical
Ingredient (API) Vildagliptin. In addition to the pricing data furnished by
NPPA
indirectly dealing in Active Pharmaceutical Ingredient
(API), pharmaceutical products, or formulations containing
Vildagliptin alone or Vildagliptin in combination with any other
compound
means, exporting, directly
or indirectly dealing in pharmaceutical products or formulations
containing Vildagliptin alone or Vildagliptin in combination with any
other compound or formulation
means, exporting, directly or indirectly
dealing in pharmaceutical products or formulations containing Vildagliptin alone or
Vildagliptin in combination with any other compound or formulation
